Apellis Pharmaceuticals (APLS) Insider Trading & Ownership $16.74 -0.55 (-3.15%) As of 11:49 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Apellis Pharmaceuticals (NASDAQ:APLS) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage6.50%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)9Amount OfInsider Selling(Last 12 Months)$4.75 M Get APLS Insider Trade Alerts Want to know when executives and insiders are buying or selling Apellis Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address APLS Insider Buying and Selling by Quarter Apellis Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails3/17/2025James George ChopasCAOSell183$24.82$4,542.06 3/5/2025David O WatsonGeneral CounselSell5,569$25.10$139,781.90 2/11/2025Mark Jeffrey DelongInsiderSell363$28.54$10,360.02 1/29/2025Cedric FrancoisCEOSell2,824$29.52$83,364.48 1/29/2025David O WatsonGeneral CounselSell695$29.52$20,516.40 1/29/2025Nur NicholsonInsiderSell825$29.52$24,354.00 1/29/2025Timothy Eugene SullivanCFOSell546$29.52$16,117.92 1/22/2025Cedric FrancoisCEOSell13,551$30.43$412,356.93 1/22/2025David O WatsonGeneral CounselSell3,323$30.43$101,118.89 1/22/2025James George ChopasCAOSell1,096$30.43$33,351.28 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 1/22/2025Nur NicholsonInsiderSell3,948$30.43$120,137.64 1/22/2025Timothy Eugene SullivanCFOSell3,088$30.43$93,967.84 1/17/2025Cedric FrancoisCEOSell6,007$29.96$179,969.72 1/17/2025David O WatsonGeneral CounselSell2,201$29.96$65,941.96 1/17/2025James George ChopasCAOSell715$29.96$21,421.40 1/17/2025Nur NicholsonInsiderSell2,145$29.96$64,264.20 1/17/2025Timothy Eugene SullivanCFOSell1,730$29.96$51,830.80 1/13/2025Cedric FrancoisCEOSell6,247$28.70$179,288.90 1/13/2025David O WatsonGeneral CounselSell4,965$28.70$142,495.50 1/13/2025James George ChopasCAOSell783$28.70$22,472.10 1/13/2025Jeffrey EiseleInsiderSell264$28.70$7,576.80 1/13/2025Timothy Eugene SullivanCFOSell2,170$28.70$62,279.00 1/6/2025Caroline BaumalInsiderSell2,816$33.81$95,208.96 12/23/2024Jeffrey EiseleInsiderSell63$33.09$2,084.67 9/16/2024A. Sinclair DunlopDirectorSell37,000$36.23$1,340,510.00 6/21/2024A. Sinclair DunlopDirectorSell37,000$39.24$1,451,880.00 (Data available from 1/1/2013 forward) APLS Insider Trading Activity - Frequently Asked Questions Who is on Apellis Pharmaceuticals's Insider Roster? The list of insiders at Apellis Pharmaceuticals includes A. Sinclair Dunlop, Adam J Townsend, Alec Machiels, Caroline Baumal, Cedric Francois, David O Watson, Federico Grossi, James George Chopas, Jeffrey Eisele, Karen Lewis, Lukas Scheibler, Mark Jeffrey Delong, Nur Nicholson, Pascal Deschatelets, Timothy Eugene Sullivan, and Victoria L Brown. Learn more on insiders at APLS. What percentage of Apellis Pharmaceuticals stock is owned by insiders? 6.50% of Apellis Pharmaceuticals stock is owned by insiders. Learn more on APLS's insider holdings. Which Apellis Pharmaceuticals insiders have been selling company stock? The following insiders have sold APLS shares in the last 24 months: A. Sinclair Dunlop ($3,860,569.58), Adam J Townsend ($299,644.96), Alec Machiels ($535,550.00), Caroline Baumal ($260,406.51), Cedric Francois ($27,807,175.10), David O Watson ($2,125,341.21), James George Chopas ($247,659.33), Jeffrey Eisele ($42,858.73), Karen Lewis ($430,000.00), Lukas Scheibler ($600,000.00), Mark Jeffrey Delong ($580,440.96), Nur Nicholson ($1,809,030.44), Pascal Deschatelets ($11,046,197.64), and Timothy Eugene Sullivan ($8,121,551.61). How much insider selling is happening at Apellis Pharmaceuticals? Insiders have sold a total of 1,035,009 Apellis Pharmaceuticals shares in the last 24 months for a total of $57,766,426.07 sold. Apellis Pharmaceuticals Key ExecutivesDr. Cedric Francois M.D. (Age 52)Ph.D., Co-Founder, President, CEO & Director Compensation: $1.44MMr. Alec Machiels J.D. (Age 51)MBA, Co-Founder & Director Compensation: $90.62kMr. Timothy E. Sullivan (Age 53)CFO & Treasurer Compensation: $793.43k4 recent tradesMr. Adam J. Townsend (Age 46)Chief Operating Officer Compensation: $770.44kMr. David O. Watson Esq. (Age 51)J.D., General Counsel Compensation: $764.37k5 recent tradesDr. Caroline R. Baumal M.D. (Age 56)Chief Medical Officer Compensation: $1.01MDr. Pascal Deschatelets Ph.D. (Age 54)Co-Founder & Chief Scientific Officer Compensation: $688.05kMr. James G. Chopas CPA (Age 57)VP, Corporate Controller & Chief Accounting Officer Ms. Meredith KayaSenior Vice President, Investor Relations & Strategic FinanceMs. Karen Lewis (Age 51)Chief People Officer More Insider Trading Tools from MarketBeat Related Companies Roivant Sciences Insider Transactions Revolution Medicines Insider Transactions Lantheus Insider Transactions BridgeBio Pharma Insider Transactions Blueprint Medicines Insider Transactions Sarepta Therapeutics Insider Transactions TG Therapeutics Insider Transactions Verona Pharma Insider Transactions Axsome Therapeutics Insider Transactions ADMA Biologics Insider Transactions Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 5 Hot Small-Cap Insiders Bought at the Peak of Tariff FearsThe Top-Ranked Insider Buys From April by Market CapMcDonald’s Insiders Sell Shares! Investors Should Do the Opposite5 Mid-Cap Stocks Insiders Are Buying This YearInsider Buying in This Stock Reiterates Analysts Bullish Outlook This page (NASDAQ:APLS) was last updated on 5/14/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredSilver’s 332% Surge?Silver has quietly become one of the most promising investments of this cycle. Russia is now stockpiling silve...Lear Capital | SponsoredWatch This Robotics Demo Before July 23rdJeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... ...Brownstone Research | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTrump Quietly Planning $15 Trillion Crypto ShockerMost investors are still unaware, but I believe a new White House action may have quietly opened the floodgate...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Apellis Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Apellis Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy APLS Stock Free APLS Stock Alerts